Acne |
||
Ch 1 –
Pathology and Mechanism of Disease
James Q. Del Rosso, DO
Entered Activity
|
James Q. Del Rosso, DO | |
Ch 2 –
Clinical Presentations
Julie Harper, MD
Entered Activity
|
Julie Harper, MD | |
Ch 3 –
Diagnosis and Assessment
James Q. Del Rosso, DO
Entered Activity
|
James Q. Del Rosso, DO | |
Ch 4 –
Skin of Color Implications
Andrew F. Alexis, MD, MPH
Entered Activity
|
Andrew F. Alexis, MD, MPH | |
Ch 5 –
Available Topical/Non-systemic Treatments
Emmy M. Graber, MD
Entered Activity
|
Emmy M. Graber, MD | |
Ch 6 –
Emerging Topical Treatments
Linda F. Stein Gold, MD
Entered Activity
|
Linda F. Stein Gold, MD | |
Ch 7 –
High Level Overview of Current Systemic Therapies
Linda F. Stein Gold, MD
Entered Activity
|
Linda F. Stein Gold, MD | |
Ch 8 –
High Level Overview of Emerging Systemic Therapies
James Q. Del Rosso, DO
Entered Activity
|
James Q. Del Rosso, DO | |
Alopecia Areata |
||
Ch 1 –
Pathology and Mechanism of Disease
Brett A. King, MD, PhD
Entered Activity
|
Brett A. King, MD, PhD | |
Ch 2 –
Clinical Presentations
Brittany Craiglow, MD
Entered Activity
|
Brittany Craiglow, MD | |
Ch 3 –
Diagnosis and Assessment
Brittany Craiglow, MD
Entered Activity
|
Brittany Craiglow, MD | |
Ch 4 –
Available Topical/Non-systemic Treatments
Amy McMichael, MD
Entered Activity
|
Amy McMichael, MD | |
Ch 5 –
Emerging Topical Treatments
Gary Goldenberg, MD
Entered Activity
|
Gary Goldenberg, MD | |
Ch 6 –
High Level Overview of Emerging Systemic Therapies
Brett A. King, MD, PhD
Entered Activity
|
Brett A. King, MD, PhD | |
Atopic Dermatitis |
||
Ch 1 –
Pathology and Mechanism of Disease
Lawrence Eichenfield, MD
Entered Activity
|
Lawrence Eichenfield, MD | |
Ch 2 –
Clinical Presentations
Peter A. Lio, MD
Entered Activity
|
Peter A. Lio, MD | |
Ch 3 –
Diagnosis and Assessment
Peter A. Lio, MD
Entered Activity
|
Peter A. Lio, MD | |
Ch 4 –
Skin of Color Implications
Andrew F. Alexis, MD, MPH
Entered Activity
|
Andrew F. Alexis, MD, MPH | |
Ch 5 –
Available Topical/Non-systemic Treatments
Lawrence Eichenfield, MD
Entered Activity
|
Lawrence Eichenfield, MD | |
Ch 6 –
Emerging Topical Treatments
Jonathan I. Silverberg, MD, PhD, MPH
Entered Activity
|
Jonathan I. Silverberg, MD, PhD, MPH | |
Ch 7 –
High Level Overview of Current Systemic Therapies
Lawrence Eichenfield, MD
Entered Activity
|
Lawrence Eichenfield, MD | |
Ch 8 –
High Level Overview of Emerging Systemic Therapies
Mark Lebwohl, MD
Entered Activity
|
Mark Lebwohl, MD | |
Psoriasis |
||
Ch 1 –
Pathology and Mechanism of Disease
April Armstrong, MD, MPH
Entered Activity
|
April Armstrong, MD, MPH | |
Ch 2 –
Clinical Presentations
April Armstrong, MD, MPH
Entered Activity
|
April Armstrong, MD, MPH | |
Ch 3 –
Diagnosis and Assessment
Melinda J. Gooderham, MD, MSc
Entered Activity
|
Melinda J. Gooderham, MD, MSc | |
Ch 4 –
Skin of Color Implications
Andrew F. Alexis, MD, MPH
Entered Activity
|
Andrew F. Alexis, MD, MPH | |
Ch 5 –
Available Topical/Non-systemic Treatments
John Y. M. Koo, MD
Entered Activity
|
John Y. M. Koo, MD | |
Ch 6 –
Emerging Topical Treatments
April Armstrong, MD, MPH
Entered Activity
|
April Armstrong, MD, MPH | |
Ch 7 –
High Level Overview of Current Systemic Therapies
April Armstrong, MD, MPH
Entered Activity
|
April Armstrong, MD, MPH | |
Ch 8 –
High Level Overview of Emerging Systemic Therapies
John Y. M. Koo, MD
Entered Activity
|
John Y. M. Koo, MD | |
Psoriatic Arthritis |
||
Ch 1 –
Pathology and Mechanism of Disease
Joseph F. Merola, MD, MMSc
Entered Activity
|
Joseph F. Merola, MD, MMSc | |
Ch 2 –
Clinical Presentations
Alice B. Gottlieb, MD, PhD
Entered Activity
|
Alice B. Gottlieb, MD, PhD | |
Ch 3 –
Diagnosis and Assessment
Alice B. Gottlieb, MD, PhD
Entered Activity
|
Alice B. Gottlieb, MD, PhD | |
Ch 4 –
High Level Overview of Current Systemic Therapies
April Armstrong, MD, MPH
Entered Activity
|
April Armstrong, MD, MPH | |
Ch 5 –
High Level Overview of Emerging Systemic Therapies
Saakshi Khattri, MD
Entered Activity
|
Saakshi Khattri, MD | |
Vitiligo |
||
Ch 1 –
Pathology and Mechanism of Disease
Andrew F. Alexis, MD, MPH
Entered Activity
|
Andrew F. Alexis, MD, MPH | |
Ch 2 –
Clinical Presentations
Seemal R. Desai, MD
Entered Activity
|
Seemal R. Desai, MD | |
Ch 3 –
Diagnosis and Assessment
Melinda J. Gooderham, MD, MSc
Entered Activity
|
Melinda J. Gooderham, MD, MSc | |
Ch 4 –
Skin of Color Implications
Iltefat Hamzavi, MD
Entered Activity
|
Iltefat Hamzavi, MD | |
Ch 5 –
Available Topical/Non-systemic Treatments
David Rosmarin, MD
Entered Activity
|
David Rosmarin, MD | |
Ch 6 –
Emerging Topical Treatments
Seemal R. Desai, MD
Entered Activity
|
Seemal R. Desai, MD | |
Ch 7 –
High Level Overview of Current Systemic Therapies
David Rosmarin, MD
Entered Activity
|
David Rosmarin, MD | |
Ch 8 –
High Level Overview of Emerging Systemic Therapies
Iltefat Hamzavi, MD
Entered Activity
|
Iltefat Hamzavi, MD | |
Navigating Access Hurdles |
||
Ch 1 –
Navigating Access Hurdles
Mark Lebwohl, MD
Entered Activity
|
Mark Lebwohl, MD |